These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8757382)

  • 21. HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells.
    Liu G; Ying H; Zeng G; Wheeler CJ; Black KL; Yu JS
    Cancer Res; 2004 Jul; 64(14):4980-6. PubMed ID: 15256472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic modulation combined with PD-1/PD-L1 blockade enhances immunotherapy based on MAGE-A11 antigen-specific CD8+T cells against esophageal carcinoma.
    Wu Y; Sang M; Liu F; Zhang J; Li W; Li Z; Gu L; Zheng Y; Li J; Shan B
    Carcinogenesis; 2020 Jul; 41(7):894-903. PubMed ID: 32529260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder.
    Patard JJ; Brasseur F; Gil-Diez S; Radvanyi F; Marchand M; François P; Abi-Aad A; Van Cangh P; Abbou CC; Chopin D
    Int J Cancer; 1995 Feb; 64(1):60-4. PubMed ID: 7665250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MAGE-1 and related MAGE gene expression may be associated with hepatocellular carcinoma.
    Liu BB; Ye SL; He P; Liu YK; Tang ZY
    J Cancer Res Clin Oncol; 1999 Dec; 125(12):685-9. PubMed ID: 10592101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of MAGE, GAGE and BAGE genes in human liver diseases: utility as molecular markers for hepatocellular carcinoma.
    Kobayashi Y; Higashi T; Nouso K; Nakatsukasa H; Ishizaki M; Kaneyoshi T; Toshikuni N; Kariyama K; Nakayama E; Tsuji T
    J Hepatol; 2000 Apr; 32(4):612-7. PubMed ID: 10782910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylated CpG points identified within MAGE-1 promoter are involved in gene repression.
    Serrano A; García A; Abril E; Garrido F; Ruiz-Cabello F
    Int J Cancer; 1996 Nov; 68(4):464-70. PubMed ID: 8945617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules.
    Adair SJ; Hogan KT
    Cancer Immunol Immunother; 2009 Apr; 58(4):589-601. PubMed ID: 18791715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma.
    Li B; Zhu X; Sun L; Yuan L; Zhang J; Li H; Ye Z
    Oncotarget; 2014 Nov; 5(21):10791-802. PubMed ID: 25301731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of MAGE-1 gene by esophageal carcinomas.
    Toh Y; Yamana H; Shichijo S; Fujita H; Tou U; Sakaguchi M; Kakegawa T; Itoh K
    Jpn J Cancer Res; 1995 Aug; 86(8):714-7. PubMed ID: 7559092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of melanoma antigen-encoding genes (MAGE) by common primers for MAGE-A1 to -A6 in colorectal carcinomas among Koreans.
    Park MS; Park JW; Jeon CH; Lee KD; Chang HK
    J Korean Med Sci; 2002 Aug; 17(4):497-501. PubMed ID: 12172045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular strategy for detecting metastatic cancers with use of multiple tumor-specific MAGE-A genes.
    Miyashiro I; Kuo C; Huynh K; Iida A; Morton D; Bilchik A; Giuliano A; Hoon DS
    Clin Chem; 2001 Mar; 47(3):505-12. PubMed ID: 11238304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura.
    Schrump DS; Fischette MR; Nguyen DM; Zhao M; Li X; Kunst TF; Hancox A; Hong JA; Chen GA; Pishchik V; Figg WD; Murgo AJ; Steinberg SM
    Clin Cancer Res; 2006 Oct; 12(19):5777-85. PubMed ID: 17020984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine.
    Sigalotti L; Fratta E; Coral S; Tanzarella S; Danielli R; Colizzi F; Fonsatti E; Traversari C; Altomonte M; Maio M
    Cancer Res; 2004 Dec; 64(24):9167-71. PubMed ID: 15604288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the MAGE-1, -2, -3, -4, and -6 genes in non-squamous cell carcinoma lesions of the head and neck.
    Lee KD; Eura M; Ogi K; Nakano K; Chikamatsu K; Masuyama K; Ishikawa T
    Acta Otolaryngol; 1996 Jul; 116(4):633-9. PubMed ID: 8831854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells.
    Wischnewski F; Pantel K; Schwarzenbach H
    Mol Cancer Res; 2006 May; 4(5):339-49. PubMed ID: 16687489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcription of the MAGE-1 gene and the methylation status of its Ets binding promoter elements: a quantitative analysis in melanoma cell lines using a real-time polymerase chain reaction technique.
    Janssen BL; van de Locht LT; Fourkour A; de Smet C; Mensink EJ; van Muijen GN; de Vries TJ
    Melanoma Res; 1999 Jun; 9(3):213-22. PubMed ID: 10465576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the MAGE gene family in human head-and-neck squamous-cell carcinomas.
    Eura M; Ogi K; Chikamatsu K; Lee KD; Nakano K; Masuyama K; Itoh K; Ishikawa T
    Int J Cancer; 1995 Oct; 64(5):304-8. PubMed ID: 7591301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High frequency of expression of MAGE genes in human hepatocellular carcinoma.
    Chen CH; Huang GT; Lee HS; Yang PM; Yan MD; Chen DS; Sheu JC
    Liver; 1999 Apr; 19(2):110-4. PubMed ID: 10220740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infrequent expression of the MAGE gene family in uveal melanomas.
    Mulcahy KA; Rimoldi D; Brasseur F; Rodgers S; Liénard D; Marchand M; Rennie IG; Murray AK; McIntyre CA; Platts KE; Leyvraz S; Boon T; Rees RC
    Int J Cancer; 1996 Jun; 66(6):738-42. PubMed ID: 8647642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expressions of MAGE-A9 and MAGE-A11 in breast cancer and their expression mechanism.
    Hou SY; Sang MX; Geng CZ; Liu WH; Lü WH; Xu YY; Shan BE
    Arch Med Res; 2014 Jan; 45(1):44-51. PubMed ID: 24316396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.